(19)
(11) EP 4 210 686 A1

(12)

(43) Date of publication:
19.07.2023 Bulletin 2023/29

(21) Application number: 21773100.9

(22) Date of filing: 08.09.2021
(51) International Patent Classification (IPC): 
A61K 31/137(2006.01)
A61K 31/4245(2006.01)
A61K 31/4468(2006.01)
A61K 31/496(2006.01)
A61K 31/513(2006.01)
A61K 31/7105(2006.01)
A61P 9/00(2006.01)
A61K 31/27(2006.01)
A61K 31/445(2006.01)
A61K 31/495(2006.01)
A61K 31/506(2006.01)
A61K 31/5375(2006.01)
A61K 45/06(2006.01)
A61P 9/10(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/4468; A61K 31/445; A61K 31/137; A61K 31/5375; A61K 31/495; A61K 31/496; A61K 31/513; A61K 31/4245; A61K 31/27; A61K 31/506; A61K 31/7105; A61K 45/06; A61P 9/00; A61P 9/10
 
C-Sets:
  1. A61K 31/4468, A61K 2300/00;
  2. A61K 31/495, A61K 2300/00;
  3. A61K 31/496, A61K 2300/00;
  4. A61K 31/506, A61K 2300/00;
  5. A61K 31/513, A61K 2300/00;
  6. A61K 31/137, A61K 2300/00;
  7. A61K 31/7105, A61K 2300/00;
  8. A61K 31/27, A61K 2300/00;
  9. A61K 31/5375, A61K 2300/00;
  10. A61K 31/4245, A61K 2300/00;
  11. A61K 31/445, A61K 2300/00;

(86) International application number:
PCT/EP2021/074718
(87) International publication number:
WO 2022/053520 (17.03.2022 Gazette 2022/11)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 08.09.2020 EP 20305993

(71) Applicants:
  • Université d'Aix-Marseille
    13007 Marseille (FR)
  • Institut National de la Santé et de la Recherche Médicale
    75013 Paris (FR)

(72) Inventor:
  • PUCEAT, Michel
    13014 Marseille (FR)

(74) Representative: LLR 
11, boulevard de Sébastopol
75001 Paris
75001 Paris (FR)

   


(54) LSD1 INHIBITORS FOR USE IN THE TREATMENT AND PREVENTION OF FIBROSIS OF TISSUES